PharmChem, Inc. common stock is traded on the OTC/Pink Sheets under the symbol ’PCHM.PK’. On March 26, 2004, the Company filed Form 15 under Rule 12g-2 of the 1934 Securities Exchange Act, whereby all reports required to be filed by Section 13(a) - including Forms 10-K, 10-Q & 8-K - are immediately suspended. As a result, the Company does not submit financial and other reports to the Securities and Exchange Commission.

Our CUISP number is 717133

Our Transfer Agent is

Phone: (503) 227 2950 Fax: (503) 227 6874

PharmChem, Inc. Company Contacts: 

Main Number: 855-458-4100

Joe Halligan (CEO)
David Lattanzio (VP & CFO)
Dana Fricke (VP & Controller)
Kerri Wagner (President)

2016 Letter to Stockholders 2015 Letter to Stockholders 2014 Letter to Stockholders 2013 Letter to Stockholders 2011 Letter to Stockholders 2004 Special Meeting of Stockholders